Case Name: In re ROSUVASTATIN CALCIUM PATENT LITIGATION. Astrazeneca UK Limited, IPR Pharmaceuticals Inc., and Shionogi Seiyaku Kabushiki Kaisha, Plaintiffs-Appellees, v. Aurobindo Pharma Limited, Defendant-Appellant, and Mylan Pharmaceuticals Inc., Defendant-Appellant, and Apotex Corp., Defendant-Appellant, and Cobalt Pharmaceuticals Inc. and Cobalt Laboratories Inc., Defendants-Appellants, and Sun Pharmaceutical Industries, Ltd., Defendant-Appellant, and Teva Pharmaceuticals USA, Inc., Defendant-Appellant, and PAR Pharmaceutical, Inc., Defendant-Appellant, and Sandoz, Inc., Defendant
Court: United States Court of Appeals for the Federal Circuit
Jurisdiction: United States
Decision Date: 2011-03-24
Citations: 413 F. App'x 288
Docket Number: Nos. 2010-1460, 2010-1461, 2010-1462, 2010-1463, 2010-1464, 2010-1465, 2010-1466, 2010-1467, 2010-1468, 2010-1469, 2010-1470, 2010-1471, 2010-1472, 2010-1473
Parties: In re ROSUVASTATIN CALCIUM PATENT LITIGATION. Astrazeneca UK Limited, IPR Pharmaceuticals Inc., and Shionogi Seiyaku Kabushiki Kaisha, Plaintiffs-Appellees, v. Aurobindo Pharma Limited, Defendant-Appellant, and Mylan Pharmaceuticals Inc., Defendant-Appellant, and Apotex Corp., Defendant-Appellant, and Cobalt Pharmaceuticals Inc. and Cobalt Laboratories Inc., Defendants-Appellants, and Sun Pharmaceutical Industries, Ltd., Defendant-Appellant, and Teva Pharmaceuticals USA, Inc., Defendant-Appellant, and PAR Pharmaceutical, Inc., Defendant-Appellant, and Sandoz, Inc., Defendant.
Judges: 
Reporter: West's Federal Appendix
Volume: 413
Pages: 288–289

Head Matter:
In re ROSUVASTATIN CALCIUM PATENT LITIGATION. Astrazeneca UK Limited, IPR Pharmaceuticals Inc., and Shionogi Seiyaku Kabushiki Kaisha, Plaintiffs-Appellees, v. Aurobindo Pharma Limited, Defendant-Appellant, and Mylan Pharmaceuticals Inc., Defendant-Appellant, and Apotex Corp., Defendant-Appellant, and Cobalt Pharmaceuticals Inc. and Cobalt Laboratories Inc., Defendants-Appellants, and Sun Pharmaceutical Industries, Ltd., Defendant-Appellant, and Teva Pharmaceuticals USA, Inc., Defendant-Appellant, and PAR Pharmaceutical, Inc., Defendant-Appellant, and Sandoz, Inc., Defendant.
Nos. 2010-1460, 2010-1461, 2010-1462, 2010-1463, 2010-1464, 2010-1465, 2010-1466, 2010-1467, 2010-1468, 2010-1469, 2010-1470, 2010-1471, 2010-1472, 2010-1473.
United States Court of Appeals, Federal Circuit.
March 24, 2011.

Opinion:
MOTION
ORDER
Apotex Corp. moves for separate oral argument with respect to an issue in these appeals.
Upon consideration thereof,
It Is Ordered That:
The motion is deferred for consideration by the merits panel assigned to hear this case. Copies of this order, the motion and any response shall be transmitted to the merits panel.